Presentation of the Center
The Oslo University Hospital (OUH) since 2009 includes the merger between the oncology departments of the Norwegian Radium Hospital (NRH) and the Ulleval Hospital, creating a large oncology center with joint leadership and administration.
The Norwegian Radium Hospital (NRH) and the Cancer Research Institute have been a milestone in cancer research. The proximity of the two centers and the close collaboration between clinicians and researchers are key factors for the success of the oncology center.
Main Research Activities
Main objectives of the Integrated Research and Patient Treatment of the OUH at the International Level:
- Improvement of the quality of all basic, clinical, and translational research
- Increase in research output by 20% by 2016
- Research groups are multidisciplinary and cooperate systematically
- Research is relevant to clinical activities
- Research activity is visible
Current areas of interest:
- Cancer Biomedicine
- Stem Cell Research
- Cancer Immunotherapy
- High Precision Radiotherapy
- Personalized Cancer Therapy
- Breast Cancer and Colorectal Cancer
Centers of Excellence
The OUH has an institutional cooperation with the MD Anderson Cancer Center, USA. The following centers of excellence have been named:
- Center for Cancer Biomedicine (Norwegian Research Council)
- K.G. Jebsen Centre for Breast Cancer Research
- K.G. Jebsen Centre for Cancer Immunotherapy
- K.G. Jebsen Centre for Colorectal Cancer
- Research-Driven Innovation Center (Norwegian Research Council): Stem Cell-Based Tumor Therapy
Core Facilities
The division includes core facilities for bioinformatics, confocal microscopy, electron microscopy, flow cytometry, proteomics, microarray and sequencing, genotyping, comparative medicine, and animal MRI.
A phase I clinical trial unit is part of the Department of Clinical Research, and there is a large Department of Cell Therapy that includes GMP facilities serving national and international clinical trials.
Education
The education of medical students, PhD students, oncologists, oncology nurses, and radiotherapy staff is a high priority.